PAR-24-279-Full-Announcement.html

This is an announcement for PAR-24-279, an Exploratory Clinical Trial Grants program focused on Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required). The funding opportunity is a reissue of PAR-24-035, updated only to reflect changes in Section V related to the Simplifying Review of Research Project Grant Applications.

The grant is administered by the Department of Health and Human Services National Institutes of Health (NIH) under CFDA 93.846. Eligible applicants include higher education institutions (both public and private), state and local governments, tribal organizations, nonprofits, public housing authorities, and small businesses. The program supports research into causes, treatment, and prevention of arthritis, musculoskeletal and skin diseases, including training of basic and clinical scientists. This funding opportunity requires clinical trials and is structured as an R61 grant mechanism.